title: An expanded nationwide view of chronic kidney disease in Aboriginal Australians.
abstract: We summarize new knowledge that has accrued in recent years on chronic kidney disease (CKD) in Indigenous Australians. CKD refers to all stages of preterminal kidney disease, including end-stage kidney failure (ESKF), whether or not a person receives renal replacement therapy (RRT). Recently recorded rates of ESKF, RRT, non-dialysis CKD hospitalizations and CKD attributed deaths were, respectively, more than sixfold, eightfold, eightfold and threefold those of non-Indigenous Australians, with age adjustment, although all except the RRT rates are still under-enumerated. However, the nationwide average Indigenous incidence rate of RRT appears to have stabilized. The median age of Indigenous people with ESKF was about 30 years less than for non-Indigenous people, and 84% of them received RTT, while only half of non-Indigenous people with ESKF did so. The first-ever (2012) nationwide health survey data showed elevated levels of CKD markers in Indigenous people at the community level. For all CKD parameters, rates among Indigenous people themselves were strikingly correlated with increasing remoteness of residence and socio-economic disadvantage, and there was a female predominance in remote areas. The burden of renal disease in Australian Indigenous people is seriously understated by Global Burden of Disease Mortality methodology, because it employs underlying cause of death only, and because deaths of people on RRT are frequently attributed to non-renal causes. These data give a much expanded view of CKD in Aboriginal people. Methodologic approaches must be remedied for a full appreciation of the burden, costs and outcomes of the disease, to direct appropriate policy development.
authors.affiliation: Centre for Chronic Disease, School of Medicine, The University of Queensland, St Lucia, Queensland, Australia. w.hoy@uq.edu.au.
authors.forename: Wendy E
authors.initials: WE
authors.lastname: Hoy
authors.affiliation: Centre for Chronic Disease, School of Medicine, The University of Queensland, St Lucia, Queensland, Australia.
authors.forename: Susan A
authors.initials: SA
authors.lastname: Mott
authors.affiliation: University of Adelaide and Australia and New Zealand Dialysis and Transplant Registry (ANZDATA), Adelaide, South Australia, Australia.
authors.forename: Stephen P
authors.initials: SP
authors.lastname: Mc Donald
mesh_terms: D001315:Australia / Q000453:epidemiology; D006297:Health Services Accessibility; D006303:Health Services, Indigenous / Q000592:standards / Q000706:statistics & numerical data; D006801:Humans; D015994:Incidence; D007676:Kidney Failure, Chronic / Q000453:epidemiology / Q000628:therapy; D044382:Population Groups / Q000706:statistics & numerical data*; D058996:Quality Improvement; D017582:Renal Replacement Therapy / Q000379:methods / Q000706:statistics & numerical data; D016019:Survival Analysis
keywords: Indigenous Australian; chronic kidney disease; kidney failure; renal replacement therapy